These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18279562)

  • 1. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children.
    Karvonen MK; Koulu M; Pesonen U; Uusitupa MI; Tammi A; Viikari J; Simell O; Rönnemaa T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1455-60. PubMed ID: 10770181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
    Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
    Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
    Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
    Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism and changes in serum lipids during a family-based counselling intervention.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2006 Oct; 9(7):859-65. PubMed ID: 17010251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
    Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
    Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
    Schwab US; Agren JJ; Valve R; Hallikainen MA; Sarkkinen ES; Jauhiainen M; Karvonen MK; Pesonen U; Koulu M; Uusitupa MI; Savolainen MJ
    Eur J Clin Nutr; 2002 Feb; 56(2):149-56. PubMed ID: 11857048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
    Pesonen U; Koch W; Schömig A; Kastrati A
    J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels.
    Karvonen MK; Pesonen U; Koulu M; Niskanen L; Laakso M; Rissanen A; Dekker JM; Hart LM; Valve R; Uusitupa MI
    Nat Med; 1998 Dec; 4(12):1434-7. PubMed ID: 9846584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children.
    Karvonen MK; Ruottinen S; Koulu M; Pesonen U; Niinikoski H; Rask-Nissilä L; Simell O; Rönnemaa T
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4664-8. PubMed ID: 16912140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
    Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.
    Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Dehghan-Manshadi R; Forghanifard MM; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M
    Gene; 2012 Mar; 496(1):22-7. PubMed ID: 22289186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low prevalence of the Leu7/Pro polymorphism in the signal peptide of preproneuropeptide Y in the Spanish Mediterranean population].
    Portolés O; Sorlí JV; González JI; Ruiz de la Fuente S; Ramírez JB; Corella D
    Med Clin (Barc); 2003 Mar; 120(9):337-9. PubMed ID: 12646110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
    Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.